Bank of New York Mellon’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.7M Buy
474,497
+41,190
+10% +$178K ﹤0.01% 2774
2026
Q1
$1.68M Sell
433,307
-35,538
-8% -$146K ﹤0.01% 2906
2025
Q4
$1.96M Buy
468,845
+87,226
+23% +$337K ﹤0.01% 2845
2025
Q3
$1.26M Buy
381,619
+54,249
+17% +$153K ﹤0.01% 3072
2025
Q2
$465K Sell
327,370
-4,572
-1% -$6.5K ﹤0.01% 3549
2025
Q1
$495K Buy
331,942
+4,064
+1% +$6.4K ﹤0.01% 3445
2024
Q4
$367K Sell
327,878
-6,074
-2% -$5.18K ﹤0.01% 3677
2024
Q3
$316K Sell
333,952
-87,836
-21% -$111K ﹤0.01% 3736
2024
Q2
$666K Buy
421,788
+19,301
+5% +$28K ﹤0.01% 3413
2024
Q1
$584K Sell
402,487
-43,914
-10% -$63.1K ﹤0.01% 3423
2023
Q4
$598K Sell
446,401
-8,837
-2% -$10.4K ﹤0.01% 3456
2023
Q3
$646K Buy
455,238
+22,538
+5% +$31.9K ﹤0.01% 3414
2023
Q2
$498K Buy
432,700
+53,126
+14% +$62.7K ﹤0.01% 3595
2023
Q1
$402K Buy
379,574
+44,992
+13% +$64.9K ﹤0.01% 3607
2022
Q4
$509K Sell
334,582
-1,755
-0.5% -$3.02K ﹤0.01% 3532
2022
Q3
$713K Buy
336,337
+21,839
+7% +$46K ﹤0.01% 3377
2022
Q2
$421K Sell
314,498
-4,093
-1% -$6.07K ﹤0.01% 3696
2022
Q1
$672K Sell
318,591
-17,921
-5% -$43.6K ﹤0.01% 3538
2021
Q4
$1.25M Sell
336,512
-7,386
-2% -$31.8K ﹤0.01% 3260
2021
Q3
$1.72M Buy
343,898
+26,936
+8% +$155K ﹤0.01% 3079
2021
Q2
$2.07M Buy
316,962
+15,663
+5% +$109K ﹤0.01% 2964
2021
Q1
$2.08M Buy
301,299
+19,469
+7% +$165K ﹤0.01% 2902
2020
Q4
$2.88M Buy
281,830
+679
+0.2% +$4.4K ﹤0.01% 2636
2020
Q3
$984K Sell
281,151
-4,192
-1% -$19.9K ﹤0.01% 3134
2020
Q2
$1.42M Sell
285,343
-17,107
-6% -$58.2K ﹤0.01% 2890
2020
Q1
$1.03M Sell
302,450
-16,434
-5% -$70.9K ﹤0.01% 2963
2019
Q4
$1.75M Buy
318,884
+2,024
+0.6% +$11.4K ﹤0.01% 2898
2019
Q3
$1.81M Sell
316,860
-22,693
-7% -$154K ﹤0.01% 2802
2019
Q2
$2.6M Buy
339,553
+27,968
+9% +$151K ﹤0.01% 2664
2019
Q1
$1.64M Sell
311,585
-3,853
-1% -$26.7K ﹤0.01% 2889
2018
Q4
$2.06M Buy
315,438
+10,691
+4% +$120K ﹤0.01% 2707
2018
Q3
$5.25M Buy
304,747
+26,136
+9% +$389K ﹤0.01% 2383
2018
Q2
$3.88M Buy
278,611
+43,310
+18% +$731K ﹤0.01% 2521
2018
Q1
$3.61M Sell
235,301
-1,702
-0.7% -$24.3K ﹤0.01% 2510
2017
Q4
$2.73M Sell
237,003
-370
-0.2% -$5.51K ﹤0.01% 2668
2017
Q3
$4.51M Buy
237,373
+3,234
+1% +$66.6K ﹤0.01% 2380
2017
Q2
$5.64M Buy
234,139
+15,568
+7% +$341K ﹤0.01% 2268
2017
Q1
$4.33M Sell
218,571
-11,167
-5% -$249K ﹤0.01% 2401
2016
Q4
$5.53M Buy
229,738
+18,185
+9% +$506K ﹤0.01% 2262
2016
Q3
$5.88M Sell
211,553
-6,222
-3% -$165K ﹤0.01% 2158
2016
Q2
$5.31M Buy
+217,775
New +$6.18M ﹤0.01% 2181
2016
Q1
Sell
-183,687
Closed -$5.49M 4283
2015
Q4
$5.49M Sell
183,687
-38,942
-17% -$1.31M ﹤0.01% 2160
2015
Q3
$7.83M Buy
222,629
+18,754
+9% +$915K ﹤0.01% 1991
2015
Q2
$9.86M Sell
203,875
-30,808
-13% -$1.3M ﹤0.01% 1970
2015
Q1
$10.2M Buy
234,683
+43,142
+23% +$1.55M ﹤0.01% 1949
2014
Q4
$5.04M Buy
191,541
+8,864
+5% +$194K ﹤0.01% 2311
2014
Q3
$3.24M Buy
182,677
+43,536
+31% +$889K ﹤0.01% 2565
2014
Q2
$3.34M Buy
139,141
+86,261
+163% +$1.75M ﹤0.01% 2591
2014
Q1
$1.33M Sell
52,880
-2,173
-4% -$60.2K ﹤0.01% 3145
2013
Q4
$1.25M Buy
55,053
+8,435
+18% +$170K ﹤0.01% 3167
2013
Q3
$1.05M Buy
+46,618
New +$1.08M ﹤0.01% 3216

Other funds holding PGEN

Bank of New York Mellon's PGEN Position: Q2 2026 in Review

Bank of New York Mellon increased its Precigen (PGEN) stake by 9.5% in Q2 2026, buying an estimated $178K and bringing the position to 474,497 shares worth $2.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2774.

Bank of New York Mellon first reported a position in PGEN in Q3 2013 and has held it in 51 quarters since. The position peaked at $10.2M in Q1 2015. 115 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • Bank of New York Mellon held 474,497 shares of Precigen worth $2.7M as of Q2 2026.
  • Bank of New York Mellon bought 41,190 Precigen shares in Q2 2026, an estimated $178K.
  • Precigen made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #2774 holding.
  • Bank of New York Mellon first reported a position in Precigen in Q3 2013 and has held it in 51 quarters since.
  • Bank of New York Mellon's Precigen position peaked at $10.2M in Q1 2015.
  • 115 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.